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The ability of the renal prostaglandin (PG) system
to enhance renin secretion remains a subject of
intense investigative interest and some controver-
sy. Earlier studies had isolated several factors that
could independently alter renin release: specifical-
ly, a decrease in renal perfusion pressure, the
sympathetic nervous system, or alterations in sodi-
um delivery to or transport at the macula densa
were identified as important stimuli for renin re-
lease [1]. The subsequent demonstration that sever-
al PG's are capable of independently stimulating
renin secretion has generated numerous recent in-
vestigations that probe the relative potency of the
different PG's to stimulate renin release. Moreover,
the importance of PG's for the function of other
known renin secretion stimuli (such as the arterial
baroreceptor) has also been examined.
This review highlights two distinct areas of the
prostaglandin-renin interaction: (1) PG's as primary
stimuli for renin release; and (2) PG's as integral
cofactors for other stimuli to induce the juxtaglo-
merular cells to release renin. The relative potency
of each of these stimuli will also be considered, and
areas of the relationship between PG's and renin
that particularly merit further clarification will be
emphasized.
Prostaglandins as stimuli to renin secretion
The ability of the synthetic products of PG syn-
thetase to stimulate renin release both in vivo and in
vitro has been convincingly established over the
past decade. The clearest results in these prior
studies were obtained when stimulation of other
known renin control factors (such as the renal
arterial baroreceptor) was avoided. Thus, the in-
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trarenal administration of arachidonic acid in non-
hypotensive doses in the rat [2], rabbit [3], and dog
[41 has been shown to increase renin release. Simi-
larly, the in vitro incubation of either arachidonic
acid or PGI2 in renal cortical slices of the rabbit
causes release of renin, which is inhibited by indo-
methacin, suggesting that PG's directly induce an
increase in renin release [5, 6].
Further elucidation of the PG-renin relationship
has been obtained from studies in which an inhibitor
of the cyclooxygenase step of PG synthesis has
been used. Yun et al demonstrated that the renal
hemodynamic and renin-suppressing effects of in-
domethacin were reversed by an intrarenal infusion
of PGE2 or PGE1 [7]. Prostaglandin synthesis inhi-
bition has also been shown to inhibit the release of
renin in the basal state [8, 9].
Some controversy exists regarding which of the
renal PG's is most potent in stimulating renin re-
lease. Gerber et al recently reported that PGE2 and
PGI2 were of equal potency in their capacity to
release renin in the dog [10]. In contrast, Bolger et
al found that an intrarenal infusion of PGI2 failed to
stimulate renin release [41. A potential complicating
feature of intrarenal PG infusions, however, is a
significant natriuresis and thus an increase in sodi-
um delivery to the macula densa [11, 12]. This effect
might oppose any effect of PG's to directly stimu-
late renin via the juxtaglomerular cells [13]. Fur-
thermore, the metabolism of PGE2 and PGI2 differs
and could, theoretically, account for any observed
differences in potency. To further clarify these
issues, Gerber, Keller, and Nies recently infused
several different PG compounds into the denervat-
ed, nonfiltering kidneys of dogs [14]. The use of this
experimental model allows the dissociation of the
stimulatory effects of PG's from any inhibitory
effect of sodium delivery on the macula densa
pathway to renin release and the input of the
sympathetic nervous system to renin secretion. The
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results of these infusions showed that both P012
and PGE2 were capable of stimulating renin secre-
tion in this nonfiltering model; PGI2 was a slightly
more potent stimulant for renin than POE2. Fur-
thermore, additional studies with 13, 14-dihydro-
PGE2 (a metabolite of PGE2) demonstrated greater
renin release potency than did PGI2. The 13,14-
dihydro-PGE2 was included in these studies be-
cause it is a substrate that is poorly transported into
cells, thus delaying its catabolism [14]. In summary,
these results imply that the relative potency of a
particular PG synthesis product may depend in part
on the ability of the kidney to transport and catabo-
lize the compound. Similar results with P012 and
POD2 infusions into canine denervated, nonfiltering
kidneys have yielded significant increments in renin
secretion [15]. It should be noted that although
these studies in the denervated, nonfiltering kidney
eliminate the macula densa and sympathetic ner-
vous system as interfering stimuli to renin release,
the renal baroreceptor mechanism remains func-
tional in these kidneys. Thus, the PG infusions
could alter renin secretion either indirectly via the
baroreceptor or directly via the juxtaglomerular
cells [14, 15].
To clearly isolate the direct effect of PG-induced
renin secretion on the juxtaglomerular cells and to
avoid the problem of rapid cellular uptake and
catabolism, Franco-Saenz et a! have recently devel-
oped a continuous superfusion system of rat renal
cortical slices [161. In this model, PGE2 caused a
dose-dependent stimulation of renin secretion at
concentrations of 3 x 1O to 1O M that was not
inhibited by propranolol. Dibutyryl cyclic AMP
also caused a dose-dependent release of renin at
concentrations of iO to 5 x lO- M, but theophyl-
line (at a dose of 4 x 1O M) had no effect on renin
secretion. Interestingly, when theophylline was
added to subthreshold doses of PGE2 (lO M), renin
release was significantly stimulated. Maximum
stimulating doses of PGE2 and dibutyryl cyclic
AMP had no additive or synergistic effects. Taken
together, these results in superfused kidney slices
demonstrate that POE2 causes stimulation of renin
release by a direct effect on the juxtaglomerular
cell; this stimulation does not depend on the beta-
adrenergic receptors but may be mediated in part by
cyclic AMP. Recent observations by Campbell,
Graham, and Jackson [17] differ with respect to the
dependence of the renin-stimulating effects of PG's
on cyclic AMP. Using a conscious rat model, these
workers infused dibutyryl cyclic AMP into the renal
artery (3 mg/kg/mm) and noted a significant in-
crease in serum renin activity, which was blocked
by pretreatment with indomethacin (5 mg/kg). This
result suggests that the renin stimulatory effect of
P0's is distal to the stimulatory effect of cyclic
AMP. This apparent discrepancy, however, may be
resolved with future studies in the superfused renal
cortical slice model testing the renin secretory
effects of cyclic AMP with and without prostaglan-
din inhibition.
In summary, the recent series of investigations
described above provide evidence that several PG's
are capable of producing renin secretion. The in
vivo experiments suggest renin stimulation is via
direct effects on the juxtaglomerular cells of the
kidney but do not exclude an effect on the intrarenal
baroreceptor. In vitro data demonstrate a direct
effect of several prostaglandins (for example, POE2
and P012) on the juxtaglomerular cells directly to
provoke a release of renin. The extent to which the
stimulatory effects of these PG's depend on cyclic
AMP must await further investigation.
Prostaglandins as necessary cofactors for other stimuli
to renin secretion
Renal arterial baroreceptor. A decrease in renal
perfusion pressure has been known for many years
to result in a prompt and reproducible increase in
renin secretion. But, the decrease in systemic pres-
sure may potentially activate the juxtaglomerular
cells via one of several pathways: (1) activation of
an intrinsic baroreceptor sensitive to small changes
in perfusion; (2) via efferent sympathetic nervous
system reflexes activated by systemic barorecep-
tors; and (3) via a decrease in delivery of sodium to
the macula densa.
The presence of an intravascular receptor sensi-
tive to perfusion pressure changes and capable of
stimulating renin secretion had been postulated for
many years [181. Later studies by Blame and Davis
[19] further clarified the mechanisms involved in
renal baroreceptor function in studies in which the
macula densa and sympathetic nervous system
pathways were ablated by using a nonfiltering,
denervated kidney model in the dog. These investi-
gators also performed a bilateral adrenalectomy to
reduce the influence of circulating catecholamines
on renin secretion. In these experiments, hemor-
rhage (20 mI/kg) produced a significant increase in
renin secretion. These authors subsequently ob-
served an increase in renin secretion with graded
decrements in perfusion pressure induced by a
vascular clamp around the renal artery; the increase
in renin secretion occurred even in the absence of a
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decrease in renal blood flow (RBF) 1119, 201. Thus,
this series of studies clearly documents the pres-
ence of an intrarenal, pressure-sensitive receptor
that stimulates renin secretion when perfusion pres-
sure falls. Moreover, the baroreceptor pathway is
capable of producing large increments in renin
release in the absence of other renin releasing
factors such as the sympathetic nervous system or
sodium delivery to the macula densa. Further evi-
dence of the presence of the renal baroreceptor
mechanism has been obtained in conscious sheep
subjected to graded decreases in perfusion pressure
[21]. In these studies, decreases in perfusion pres-
sure in the autoregulatory range (13 and 21 mm Hg)
resulted in prompt increases in renin secretion
although RBF and GFR were not detectably de-
creased. These studies affirm the role of the intrare-
nal baroreceptor as a rapidly-acting defense against
a decrease in systemic blood pressure via activation
of the renin-angiotensin system.
Most of the known stimuli to renin release also
result in an increase in renal PG synthesis and
release. For example, renal hypoperfusion and re-
nal nerve stimulation are known to induce the
release of PG's in addition to renin [22, 231. Several
studies have recently assessed the relationship be-
tween and dependence of the renal baroreceptor
mechanism on intact PG synthesis. In the first of
these experiments, Data et al used the denervated,
nonfiltering kidney model in adrenalectomized dogs
receiving a continuous propranolol infusion [24].
This preparation obviated the complicating influ-
ences of the macula densa and sympathetic nervous
system pathways. In the first series of studies, a
vascular clamp was used to reduce renal perfusion
pressure; RBF decreased 50% and renal venous
renin activity increased from 3.1 to 13.1 ng Al/mi/hr
(P < 0.05). When the clamping was repeated after
pretreatment with indomethacin (8 mg/kg), renal
venous renin did not increase. These studies there-
fore suggest that the integrity of the baroreceptor
mechanism is PG dependent.
Similar results in the innervated filtering kidney
have been observed by Berl et al [251 (Fig. 1). These
investigators lowered renal perfusion pressure by
aortic clamping (from 143 to 111 mm Hg) and noted
a reversible increase in plasma renin activity from
6.3 to 11.2 ng AI/ml/hr (P < 0.001). When the
clamping was repeated following pretreatment with
indomethacin, plasma renin activity did not in-
crease (4.5 to 4.0 ng Al/ml/hr [NSJ). The RBF and
the GFR were unchanged during both clamping
procedures with this amount of perfusion pressure
reduction; urinary sodium excretion declined signif-
icantly with clamping before indomethacin but was
unchanged after indomethacin. These results pro-
vide support for the PG dependence of the barore-
ceptor within the autoregulatory range in the intact
kidney; the data do not exclude a role for macula
densa sodium delivery as important, however. Fur-
ther studies using moderate hemorrhage (15 ml/kg)
as the stimulus to renin secretion also identify
baroreceptor integrity as PG dependent [261. In
these hemorrhage experiments, systemic blood
pressure was reduced by 15% of control blood
pressure via rapid arterial hemorrhage. 13-Adrener-
gic blockade with propranolol was performed to
block the sympathetic nervous system influence on
renin secretion. When renal perfusion pressure was
kept constant by means of a suprarenal aortic clamp
during the hemorrhage, renin secretion did not
increase during hemorrhage. Similarly, pretreat-
ment with indomethacin (10 mg/kg) also prevented
an increase in renin secretion when combined with
3-adrenergic blockade with this amount of hemor-
rhage. These results were observed in the context
of modest and insignificant decreases in both GFR
and RBF. Thus, in summary, the results of these
three experiments [24—26] demonstrate the renal
arterial baroreceptor pathway to renin release to be
PG dependent in the filtering kidney and nonfilter-
ing kidney studied in vivo under conditions of both
arterial clamping and hemorrhage.
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Fig. 1. Effect of aortic clamping on renal perfusion pressure and
plasma renin activity in prostaglandin-replete and -depleted
dogs. Plasma renin activity increased with clamping prior to
indomethacin (left panels), but failed to increase with repeated
clamping after treatment with indomethacin (right panels).
(Adapted from Ref 25; reprinted with permission of Am J
Physiol)
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These observations have been extended recently
by Blackshear et al [27] by studies in which renal
perfusion pressure was reduced by aortic clamping
to levels below the autoregulatory range. In the first
series of studies in intact canine kidneys, these
investigators confirmed that with a decrease in
renal perfusion pressure of 30 mm Hg (from 120 to
90 mm Hg), renin secretion increased significantly
and could be attenuated by pretreatment with either
indomethacin or meclofenemate. But, when perfu-
sion pressure was further reduced to 60 mm Hg and
RBF decreased significantly, the increase in renin
secretion was not blunted by pretreatment with
either of two PG synthesis inhibitors. These results
argue that although the renal baroreceptor is PG
dependent during reductions in perfusion pressure
in the autoregulatory range (when RBF is well
maintained), further reductions in perfusion pres-
sure result in either the arterial baroreceptor be-
coming dissociated from PG dependence (via anoth-
er efferent pathway to renin secretion) or the
macula densa mechanism (or other tubular recep-
tors) being sufficiently activated to independently
provoke renin release. These results do not distin-
guish between these two possibilities. The data are
consistent with the previous hypothesis proposed
by Blame, Davis, and Harris [28] that the arterial
baroreceptor primarily controls renin release within
the autoregulatory range of perfusion pressures and
by the macula densa mechanism (or other tubular
pathways) at perfusion pressures below this. The
results of Blackshear et al [27] also provide evi-
dence that PG's do not constitute a final common
pathway to renin secretion because renin secretion
dramatically increased when perfusion pressure
was decreased below the autoregulatory range de-
spite PG inhibition. Future investigations are need-
ed to delineate the possibility of PG-inhibition "es-
cape" of previously PG-dependent pathways from
the activation of PG-independent pathways to renin
release as responsible for these observations. More-
over, urinary or venous PG measurements should
be made in future studies in order to exclude the
real possibility that PG synthesis inhibition is not
overcome by the stimulus to renin release being
used.
Sympathetic nervous system. The adrenergic ner-
vous system is a well-known stimulus to renin
release under a variety of conditions. Electrical
stimulation of the brain stem [29, 30], of the renal
nerves [31, 32], as well as i.v. catecholamine infu-
sions [33] are known to result in increased renin
secretion. Furthermore, electron microscopy and
histochemical fluorescence studies have shown that
the juxtaglomerular cells of both rat and dog are
supplied with adrenergic nerve endings [34].
Recent studies have clarified several aspects of
the relationship between the adrenergic nervous
system and renin. The stimulation of renal sympa-
thetic nerves with a low dose of electricity (10 V;
frequency, 0.33 Hz; duration, 0.5 msec) was dem-
onstrated to provoke renin secretion (401 to 1255
U/mm) but did not affect GFR, RBF, renal vascular
resistance, systemic blood pressure, or urinary so-
dium excretion [35]. When the stimulation was
repeated after the infusion of propranolol, however,
the increase in renin secretion was abolished. These
results supported a schema in which renal nerves
stimulated the juxtaglomerular cells directly, and
this effect was mediated through 3-adrenergic re-
ceptors. Furthermore, subsequent pharmacologic
investigations have established the 3- 1 -adrenergic
receptor as responsible for renin release [36, 37].
But, 3-adrenergic blockade with propranolol does
not affect the ability of PG's to induce renin release
[16]. This finding implies that PG's have a renin
stimulatory effect either separate from or distal to
the 3-adrenergic stimulatory effect.
In the recent investigation by Berl et al [25], the
precise relationship of the 3-adrenergic receptors
and their dependence on PG's was examined in
detail in dogs. In the first group of studies, an i.v.
isoproterenol solution was found to stimulate an
increase in plasma renin activity (from 3.2 to 15.6 ng
Al/mi/hr. P < 0.001); this increase was not blunted
by prior indomethacin administration (4.8 to 14.2 ng
AI/ml/hr). But, the systemic isoproterenol infusion
also caused a decrease in renal perfusion pressure,
which could have accounted for this increase in
plasma renin independently of the 3-adrenergic
stimulation. The studies were therefore repeated
with renal perfusion maintained constant (Fig. 2)
during isoproterenol infusion by means of a supra-
renal aortic clamp. In this series of experiments, an
increase in plasma renin was again observed after
isoproterenol in both PG-synthesis-intact (11.7 to
23.8 ng AI/ml/hr, P < 0.001) and PG-synthesis-
inhibited (8.6 to 18.9 ng AI/ml/hr, P < 0.05) condi-
tions. These results in the dog strongly suggest that
a PG-synthesis-independent pathway for renin re-
lease due to 3-adrenergic stimulation exists and are
in agreement with recent studies in man [38].
A similar finding was documented by Seymour
and Zehr [391 in which i.v. isoproterenol (0.02
g/kg/min) was used to provoke renin secretion in
the presence and absence of an intrarenal infusion
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Fig. 2. Effect of isoproterenol on plasma activity in prostaglan-
din-replete and -depleted dogs with controlled renal perfusion
pressure. Plasma renin activity increased significantly in both
prostaglandin-intact (left panel) and prostaglandin-inhibited
(right panel) groups. (Adapted from Ref. 25; reprinted with
permission of Am J Physiol)
of indomethacin (0.1 mg/kg/mm) in dogs. In the
control studies, isoproterenol produced a signifi-
cant increase in plasma renin activity (from 2.54 to
8.79 ng AI/ml/hr, P < 0.05). Despite the simulta-
neous intrarenal infusion of indomethacin in a dose
documented to inhibit PG synthesis, isoproterenol
again induced an increase in plasma renin activity
(from 1.11 to 3.23 ng AI/ml/hr, P < 0.05). The
baseline plasma renin activity was lower in the
animals receiving the indomethacin, but the magni-
tude of the increase in plasma renin activity (ap-
proximately threefold) was similar for both groups
of animals. Thus, these findings and those of Ben et
a! [251 provide evidence in the dog of a PG-indepen-
dent pathway to renin release when a 3-adrenergic
agonist infusion is performed.
A similar conclusion is forthcoming from the
study by Henrich, Schrier, and Berl [261 in which
endogenous f3-adrenergic stimulation induced by
hemorrhage (15 mI/kg) was the stimulus to renin
release. In these experiments, the increase in renin
secretion observed with hemorrhage could not be
blocked with constant renal perfusion pressure,
propranolol, or indomethacin when used as solitary
blocking maneuvers. Thus, a multifactorial mecha-
nism seemed most likely to provoke renin release in
this model of moderate hemorrhage in the dog.
When renal perfusion control was combined with -
adrenergic blockade, renin secretion was blunted.
This result suggested that the arterial baroreceptor
and the 3-adrenergic nervous system constituted
the primary pathways to renin release. Because the
arterial baroreceptor was observed to be PG-depen-
dent in the earlier clamping experiments [24, 25],
PG synthesis inhibition in combination with f3-
adrenergic blockade would be expected to also
block renin secretion in this model. This, in fact,
was the observation in the next group of dogs
hemorrhaged with indomethacin and propranolol
pretreatment, lending further support to the PG-
dependent baroreceptor theory developed in the
earlier clamping studies. Finally, the combination
of PG synthesis inhibition and renal perfusion pres-
sure control would not have been expected to
attenuate renin secretion in the final group of ani-
mals unless the 3-adrenergic nervous system was
also PG-dependent. Renin secretion was observed
to increase significantly in this final group of ani-
mals, supporting the earlier conclusion by Berl et a!
[25] and Seymour and Zehr [391 that the 13-adrener-
gic nervous system pathway to renin secretion is
PG independent, at least in the dog.
Anderson et al [40] have further probed the
relationship of the endogenously stimulated 3-ad-
renergic receptor and renin release in a series of
experiments in which hypercapnic acidosis was
induced in dogs. These workers demonstrated that
hypercapnic acidosis (Pco2 to 77 mm Hg; pH, 7.04)
resulted in an increase in plasma renin activity and
renin secretion in innervated kidneys. Renal dener-
vation or 3-adrenergic blockade with propranolol
ablated these increases in renin secretion and plas-
ma renin activity. This result would suggest that
this stimulus to renin release is mediated primarily
via the 3-adrenergic component of renal nerves,
although the contribution of circulating catechol-
amines to the increase in renin in this model is
unknown. Pretreatment of the animals with indo-
methacin (5—10 mg/kg) did not, however, blunt the
increase in plasma renin activity (1.5 to 5.1 ng
AI/ml/hr, P < 0.001) or renin secretion rate in
innervated kidneys (124 to 293 U/mm, P < 0.05) in
response to hypercapnic acidosis. This finding is
most compatible with a 3-adrenergic-mediated re-
nm response induced via renal nerves and indepen-
dent of the renal PG's system. Moreover, the
results of these studies with hypercapnic acidosis
are in agreement with the data derived in dogs
undergoing hemorrhage [261 or isoproterenol infu-
sions [25, 39]. In agreement with these studies is a
recent preliminary report by Kopp et al [411 in
which low level electrical renal nerve stimulation in
the dog induced renin secretion in the presence of
PG synthesis inhibition. This finding further implies
a PG-independent pathway to renin release for the
3-adrenergic nervous system.
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The possibility that the integrity of the 13-adrener-
gic pathway to renin release is modified by the
absence of intact PG synthesis has been suggested
by recent studies by Campbell, Graham, and Jack-
son [17]. The ability of the 3-adrenergic agonists
isoproterenol and a selective 13-1 agonist (H133/22)
to stimulate renin secretion was investigated with
and without PG synthesis inhibition. In these stud-
ies in the rat, intrarenal isoproterenol caused a
fourfold increase in serum renin activity. But, iso-
proterenol infusion in the presence of indomethacin
(5 mg/kg) also caused renin to increase, but the
magnitude of the increase (about 2.6-fold) was
significantly less than the PG-synthesis-intact rats.
Two doses of the selective 3-l agonist Hl33/22 (0.3
and 1.0 mg/kg, respectively) produced stepwise
increments in serum renin activity that were statisti-
cally significant: 3.1 (control) to 10.4 (0.3-mg dose)
to 25.0 ng AI/ml/hour (1-mg/kg dose). Although the
increases in serum renin were significant in rats
pretreated with indomethacin receiving the same
doses of the 13-1 agonist, the magnitude of the
increases were again significantly less in these
animals. Neither of these drugs detectably reduced
blood pressure although effects on renal function
were not measured. These investigators also in-
fused dibutyryl cyclic AMP into the renal arteries of
rats and noted an increase in serum renin activity;
the magnitude of the increase was again diminished
by indomethacin. The authors therefore postulate
that PG's stimulate renin release at a site distal to
the 13-adrenergic receptor and cyclic AMP in the
rat. More recent studies using an intrarenal dose of
indomethacin (250 pg/kg/min) in the cat have also
been demonstrated to blunt renin release stimulated
by a 13-adrenergic infusion [423.
Certainly these discrepancies in the 13-adrenergic
data in the dog [25, 26, 39—413 and man [381 versus
the rat [17] and cat [421 may in part be related to
species variation. Further, the nature and intensity
of the 13-adrenergic stimuli may be different in these
series of studies: in the dog, endogenous renal
nerve stimulation and catecholamine release after
hemorrhage [26], hypercapnic acidosis [403, or iso-
proterenol systemically (0.018 ig/kg/rnin) [25, 39].
In the rat and cat studies, isoproterenol infusion
into the renal artery in higher doses of 100
jxg/kg/min [17] and 0.1 pgIkg/min [42], respectively,
were used as stimuli. It is also conceivable that
these higher f3-adrenergie doses stimulate other
pathways to renin release [43]. Moreover, the ca-
nine studies in which the 13-adrenergic system ap-
peared to be PG independent were not accompanied
by simultaneous measurements of PG excretion.
Therefore, it is possible that only partial cyclooxy-
genase inhibition may have been achieved with
some stimuli and that this accounts for the failure to
blunt renin secretion. Clearly, however, results in
the dog [25—271 suggest that during PG synthesis
inhibition some pathways to renin release are un-
blocked or, alternatively, a pathway may be only
partially inhibited and is capable of "escape" dur-
ing maximum stimulation. But, the data of Camp-
bell et al [17] and Feurstein and Feurstein [42] do
imply a modulating influence of PG synthesis inhibi-
tion of renin release in some species, and further
suggest a series of studies to probe this question
directly. These issues could be greatly clarified by
the use of low level direct nerve stimulation studies
(without alteration of renal hemodynamics) with
and without PG synthesis inhibition and with mea-
surements of renal venous and/or urinary PG levels.
Moreover, experiments in which both rat and dog
renal cortical slices are incubated with isoprotere-
nol and dibutyryl cyclic AMP in the presence and
absence of cyclooxygenase inhibition would serve
to significantly clarify the apparent discrepancies in
the results.
Macula densa. The relationship between the re-
nal PG system and the macula densa pathway to
renin release has been relatively unstudied. In fact,
the relative importance of the macula densa to alter
renin release is presently unclarified. Earlier studies
by Vander and Miller [13] and later Vander and
Carlson [44] suggested that decreased sodium deliv-
ery to the distal nephron enhanced renin secretion.
In these experiments, renal artery clamping pro-
duced an increase in renin release and a decrease in
sodium excretion. Subsequent administration of
hydrochlorothiazide or production of an osmotic
diuresis blunted the increases in renin when clamp-
ing was repeated. Later studies have implicated
sodium transport at the macula densa as important
for stimulation of the renin-angiotensin system [45,
46].
The ability of PG's to influence tubular fluid
sodium delivery and thereby affect renin release is
incompletely resolved at present. Prostaglandin in-
fusions into the renal artery of dog [47, 483 and man
[49, 50] have been shown to induce a natriuresis,
thus potentially influencing renin release via the
macula densa. Moreover, these agents induce
marked changes in RBF, further obscuring an inde-
pendent effect on distal tubular sodium composi-
tion. Tannenbaum et a! [lii were able to induce an
ipsilateral natriuresis with arachidonate infusion in
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a dose (<3 pg!kgImin) that avoided alterations in
GFR or RBF. This natriuresis was ablated by
administration of an inhibitor of PG synthesis.
These results suggest that products of PG synthe-
tase are natriuretic, independently of recognized
hemodynamic alterations.
In the experiments described earlier by Henrich
et al [261, the relationship between PG synthesis
and the macula densa was indirectly addressed. In
one group of animals subjected to hemorrhage
which received propranolol and indomethacin prior
to hemorrhage, renin secretion was inhibited, and
the usual increase in plasma renin activity was
blunted. This inhibition of renin secretion occurred
despite a significant fall in urinary sodium excre-
tion. Although urinary sodium excretion may not
precisely reflect sodium delivery to the macula
densa, the likelihood of a decrease in distal tubular
sodium delivery is high. These findings in this group
of dogs suggests that the macula densa stimulus
with this amount of hemorrhage is of secondary
importance in renin secretion. Alternatively, one
could argue that the macula densa stimulus was
dependent on intact PG synthesis or intact 3-adre-
nergic receptors. In the clamping studies by Black-
shear et al [271, however, renin secretion was intact
at low renal perfusion pressures (53 to 60 mm Hg)
despite PG synthesis inhibition. This observation
would support the view that the macula densa
pathway operates independently of the PG system;
as noted earlier, the results, however, are also
consistent with the possibility that a previously
inhibited process at higher renal perfusion pres-
sures becomes sufficiently intense to escape from
inhibition. The most direct study on the macula
densa and renin-PG interaction is a recent series of
experiments by Olson et al [511. These investigators
reduced distal sodium delivery with a clamp in a
kidney maximally vasodilated and undergoing 3-
blockade. In these studies, PG synthesis inhibition
blocked the expected increase in plasma renin ac-
tivity. This suggests the macula densa mechanism is
PG dependent. A similar preliminary result is forth-
coming in data obtained in the rat [521.
Summary. Figure 3 schematically depicts a repre-
sentation of the relationships that exist between the
renal PG system and renin release. Prostaglandins
may stimulate renin release directly [6, 10, 14, 161,
and clearly appear to be an intermediary step in the
function of the baroreceptor but not the 3-adrener-
gic pathway for renin release in the dog [25, 26, 39,
401 and man [381. Studies performed in the rat [171
and cat [42] suggest, however, PG modulation of
Baroreceptor pathway
[-Adrenergic pathwayj —
Rat, cat
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LRen release
Fig. 3. Schematic depiction of the prostaglandin-renin relation-
ship. See summary for detailed explanation.
the -adrenergic pathway to renin release. Finally,
although the macula densa pathway for renin re-
lease may be of relatively less importance at renal
perfusion pressures in the autoregulatory range [26,
27], recent evidence points to the likely PG depen-
dence of this pathway [51, 521. The precise location
of cyclic AMP in the PG-renin schema is presently
unclear [16, 17].
Future investigations using superfusions of corti-
cal slices and isolated renin releasing cells will be
necessary to clarify the already complicated rela-
tionship between renin secretion and PG's. Such
studies are particularly needed to answer the ques-
tions raised regarding species differences in renin
release. Similarly, in vivo experiments with low-
dose electrical nerve stimulation and specific 3-
agonist infusions in the presence and absence of
cyclooxygenase inhibition with documented inhibi-
tion of PG's are also of critical importance if a
clearer understanding of this fascinating aspect of
renal physiology is to be realized.
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